Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.890
-0.080 (-1.61%)
May 22, 2026, 12:21 PM EDT - Market open

Protara Therapeutics Statistics

Total Valuation

TARA has a market cap or net worth of $274.84 million. The enterprise value is $104.97 million.

Market Cap274.84M
Enterprise Value 104.97M

Important Dates

The last earnings date was Wednesday, May 13, 2026, before market open.

Earnings Date May 13, 2026
Ex-Dividend Date n/a

Share Statistics

TARA has 56.20 million shares outstanding. The number of shares has increased by 68.53% in one year.

Current Share Class 56.20M
Shares Outstanding 56.20M
Shares Change (YoY) +68.53%
Shares Change (QoQ) +24.97%
Owned by Insiders (%) 1.88%
Owned by Institutions (%) 72.31%
Float 49.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.51
P/TBV Ratio 1.54
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 15.69, with a Debt / Equity ratio of 0.02.

Current Ratio 15.69
Quick Ratio 15.39
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -37.27% and return on invested capital (ROIC) is -25.24%.

Return on Equity (ROE) -37.27%
Return on Assets (ROA) -24.29%
Return on Invested Capital (ROIC) -25.24%
Return on Capital Employed (ROCE) -38.28%
Weighted Average Cost of Capital (WACC) 12.50%
Revenue Per Employee n/a
Profits Per Employee -$1.38M
Employee Count46
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +52.00% in the last 52 weeks. The beta is 1.53, so TARA's price volatility has been higher than the market average.

Beta (5Y) 1.53
52-Week Price Change +52.00%
50-Day Moving Average 5.17
200-Day Moving Average 5.17
Relative Strength Index (RSI) 46.12
Average Volume (20 Days) 737,774

Short Selling Information

The latest short interest is 6.00 million, so 10.67% of the outstanding shares have been sold short.

Short Interest 6.00M
Short Previous Month 5.75M
Short % of Shares Out 10.67%
Short % of Float 12.12%
Short Ratio (days to cover) 10.53

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -70.05M
Pretax Income -63.31M
Net Income -63.31M
EBITDA -69.69M
EBIT -70.05M
Earnings Per Share (EPS) -$1.35
Full Income Statement

Balance Sheet

The company has $135.79 million in cash and $3.06 million in debt, with a net cash position of $174.37 million or $3.10 per share.

Cash & Cash Equivalents 135.79M
Total Debt 3.06M
Net Cash 174.37M
Net Cash Per Share $3.10
Equity (Book Value) 181.21M
Book Value Per Share 3.29
Working Capital 131.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.00 million and capital expenditures -$50,000, giving a free cash flow of -$63.05 million.

Operating Cash Flow -63.00M
Capital Expenditures -50,000
Depreciation & Amortization 369,000
Net Borrowing n/a
Free Cash Flow -63.05M
FCF Per Share -$1.12
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TARA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -68.53%
Shareholder Yield -68.53%
Earnings Yield -22.66%
FCF Yield -22.57%

Analyst Forecast

The average price target for TARA is $26.57, which is 443.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target $26.57
Price Target Difference 443.35%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1